Email Login
Community
News | Research | DeepLearning | Seminar | Q&A
Diabetespatchb-1458567997641.jpgPhoto: Hui Won Yun/Seoul National University

 

 

 

 

 

 

 

Scientists have unveiled a see-through wrist cuff that measures the level of glucose in the bloodstream of diabetic patients and administers a drug to lower that level if needed. It’s not yet a full-blown treatment—for one thing, the experimental version can’t provide enough of the drug to do the trick—but it should be of great use in monitoring patients.

 

It’s also an actual application for a newfangled material in sore need of one: graphene, a superthin form of carbon with interesting electronic properties. By itself, graphene can’t sense glucose, but if you dope 2-D carbon properly, it can become quite a useful elecrochemistry set. The inventors—working in South Korea, Massachusetts and Texas—doped the graphene with minute quantities of gold to get the effect they wanted. They describe their work in this week’s issue of the journal Nature.

The idea of replacing the failing function of a diabetic pancreas dates even further back than the isolation of the critical pancreatic hormone insulin, in the 1920s. Before that, doctors had hoped to transplant the pancreas itself, or part of it, but they quickly found that the immune system would reject such a graft. Even with today’s antirejection drugs such transplantation can be problematic because those drugs can have side effects worse than the diabetes itself. Besides, transplantable tissue is in short supply.

 

 

That’s why bioengineers have long wanted to devise a mechanical alternative to the organ—a robotic pancreas that would sense and then treat excessively high (or low) glucose levels in the blood. Because such a device handles both the sensing and dosing ends of the feedback loop, it’s called a closed-loop solution.

In the past year or two, the first partially automatic systems—call them semi-closed-loop devices—have hit the market. They are now used only by patients with Type 1 diabetes (or juvenile diabetes) in which the body no longer makes any insulin and so requires that it be injected. Such a robopancreas has a tiny needle that’s inserted under the skin, to detect changes in blood glucose; a computer to figure out what to do; and an insulin pump, which administers insulin through a superthin pipette, also under the skin. The three elements are linked wirelessly. 

This method can fail if the sensor takes too long to get an accurate reading or if the hormone takes too long to do its job—a difficulty known as latency. That’s one reason why today’s commercial machines still require that the patient be involved in managing the system, for instance by administering a dose of insulin before a meal.

For Type 2 diabetes, a less severe and far more common form, it may be easier to create a fully automatic closed-loop machine. In this form of the disease, the patient’s pancreas still makes insulin and may merely need a little assistance. The graphene wristband provides that help by supplying metformin, a drug that helps the body (the liver, to be precise) to respond better to the insulin that is already circulating in the bloodstream.

The wristband senses a number of things in the patient’s skin—the mechanical strain, the temperature, and above all the chemical composition of the sweat—to infer the level of blood glucose. The researchers report a lag of 15 to 20 minutes between a change in the blood and the corresponding change in the sweat, but the latency may not be too much of a problem for people with Type 2 diabetes.  

Next, the wristband shares sensor data wirelessly with a mobile device, which calculates the proper dose of  metformin and has the wristband administer it through an array of microneedles. The array goes into action when a current warms it to 41 degrees Celsius (105 °F), which makes you wonder what would happen, say, at high noon in the tropics. But at least the microneedles are unobtrusive enough to call the device minimally invasive—a selling point for needle-shy patients.

The researchers proved that the system can normalize blood sugar in lab experiments on animals. However, though the device has administered metformin to human subjects, it didn’t supply very much of the drug.

“With the present design, it seems extremely unlikely that the daily adult dose of metformin can be delivered without an unfeasibly large number of microneedles and/or an unacceptably large patch,” writes Richard Guy, a researcher in pharmacology at the UK’s University of Bath.

Also, unlike today’s semi-automatic robopancreas devices, the wristband does nothing to correct excessively low blood glucose, which typically comes after overcorrecting the opposite problem. “Nevertheless, it is probably safe to say that these issues are already being addressed and that other therapeutic strategies are being identified to complement the significant advances achieved in this work,” Guy concludes.

Meanwhile, there’s the simple advantage of using a see-through band just as a sensor. With no muss or pain, the band can tell you how much glucose is coursing through your veins and leave it to you to do something about it.

This story was corrected, on March 23, to explain how the drug metformin works.

 

http://spectrum.ieee.org/the-human-os/biomedical/bionics/graphene-wristband-senses-your-bloodsugarand-treats-it?bt_alias=b'eyJ1c2VySWQiOiAiMjNhZTU1YzktY2Y2Yy00YjM4LThkNzctYWVlMjVkOWY1ZGFjIn0='

번호 제목 글쓴이 날짜 조회 수
공지 2019 IVPL 송년회 [1] yjchoi 2019.12.20 347
공지 [한국과총]글로벌 현장연수 참가자 모집 GreatMind 2018.04.04 371
공지 Inform Your Students: Global Student Challenge. Over US$2,000 in Prizes! GreatMind 2017.01.12 4432
공지 nVidia Parallel Computing Software Engineer 채용 GreatMind 2016.11.16 798
29 GTC Korea 2016 (코엑스 인터컨티넨탈호텔)...!!!!! GreatMind 2016.08.26 480
28 Bringing Big Neural Networks to Self-Driving Cars, Smartphones, and Drones GreatMind 2016.04.08 494
27 [News] IVPL 김병규 교수 2018 연구/산학협력 우수교원으로 선정....!!!! GreatMind 2018.12.17 523
26 Scopus Newsletter: CiteScore metrics Special Edition..!!! GreatMind 2016.12.16 533
25 [News] Prof. Lee Kye-Shin has visited to our group.....!!!! file GreatMind 2016.07.05 554
24 Google Is Helping the Pentagon Build AI for Drones GreatMind 2018.03.09 557
» Graphene Wristband Senses Your Blood Sugar—and Treats It [1] GreatMind 2016.04.09 606
22 [News] Congratulations..!!!! Young-Ju Choi's research paper has been accepted for presentation in ACiVS 2020 (Auckland, New Zealand)!!! GreatMind 2019.11.09 645
21 [News] Mr. Kim Hyun-Teak visited to our lab. to collaborate with us..!!! [12] file GreatMind 2018.02.12 706
20 Graphene Could Help Generate Power From Rain GreatMind 2016.04.08 740
19 카이스트, 모바일용 딥 러닝 AI반도체 개발 GreatMind 2018.03.06 748
18 JPL's AI-Powered Racing Drone Challenges Pro Human Pilot GreatMind 2017.12.20 751
17 nVidia Parallel Computing Software Engineer 채용 GreatMind 2016.11.16 798
16 [Notice] Dr. Kalyan's paper has been accepted as minor revision in IEEE Transactions on Industrial Electronics...!!! GreatMind 2017.12.26 811
15 Automatic emergency braking systems need 180-degree frontal vision to help cars avoid hitting cyclists..!!! GreatMind 2018.05.10 819
14 [Notice] Mr. Park's paper has been accepted with minor revision in Displays Journal (Elsevier)...!! GreatMind 2016.05.11 858
13 NVIDIA AI CONFERENCE 2019 GreatMind 2019.06.21 919
12 [Notice] Mr. Lee Jong-Hyeok has been nominated in Marquis Who's Who in the World ...!! GreatMind 2017.09.07 1109
11 Carnegie Mellon Solves 12-Year-Old DARPA Grand Challenge Mystery..!!! GreatMind 2017.10.26 1120
10 [News] Congratulation...!!! Dr. Kalyan's paper has been accepted for publication in the IEEE Transactions on Industrial Electronics...!!! GreatMind 2018.03.02 1201